Medikit Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3921060004
JPY
2,827.00
327 (13.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
23,781.46
22,553.24
21,850.54
21,607.23
20,130.70
19,312.66
19,893.20
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
23,781.46
22,553.24
21,850.54
21,607.23
20,130.70
19,312.66
19,893.20
Raw Material Cost
15,343.73
14,222.07
13,429.46
13,560.68
12,185.56
11,949.44
11,808.89
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.67
0.00
0.00
0.00
7.36
0.00
0.00
Selling and Distribution Expenses
3,867.26
3,574.18
3,468.76
3,609.32
3,198.55
3,231.22
3,542.42
Other Expenses
29.17
27.15
27.84
32.31
32.06
35.80
21.85
Total Expenditure (Excl Depreciation)
19,510.33
18,067.80
17,176.66
17,493.10
15,712.07
15,538.65
15,569.85
Operating Profit (PBDIT) excl Other Income
4271.1
4485.400000000001
4673.9
4114.1
4418.6
3774
4323.3
Other Income
248.74
174.32
27.15
52.23
112.12
154.88
11.62
Operating Profit (PBDIT)
6,559.15
6,349.40
6,245.70
5,490.09
5,800.66
5,237.56
5,653.52
Interest
7.67
0.00
0.00
0.00
7.36
0.00
0.00
Exceptional Items
0.00
-0.06
74.12
124.97
-50.58
0.00
0.00
Gross Profit (PBDT)
8,437.73
8,331.17
8,421.09
8,046.55
7,945.14
7,363.22
8,084.31
Depreciation
2,039.29
1,689.65
1,544.66
1,323.73
1,269.91
1,308.67
1,318.56
Profit Before Tax
4,512.20
4,659.70
4,775.16
4,291.34
4,472.80
3,928.89
4,334.96
Tax
1,506.11
1,646.16
1,705.69
1,426.75
1,479.79
1,269.88
1,446.97
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,006.08
3,013.54
3,069.47
2,864.59
2,993.02
2,659.01
2,887.99
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,006.08
3,013.54
3,069.47
2,864.59
2,993.02
2,659.01
2,887.99
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,006.08
3,013.54
3,069.47
2,864.59
2,993.02
2,659.01
2,887.99
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
46,781.03
45,156.02
44,128.54
47,291.98
45,772.32
43,636.63
42,169.15
Earnings per share (EPS)
206.38
204.56
187.95
170.67
178.15
157.37
170.33
Diluted Earnings per share
206.38
204.56
187.95
170.67
178.15
157.37
170.33
Operating Profit Margin (Excl OI)
17.96%
19.89%
21.39%
19.04%
21.95%
19.54%
21.73%
Gross Profit Margin
27.55%
28.15%
28.92%
25.99%
28.53%
27.12%
28.42%
PAT Margin
12.64%
13.36%
14.05%
13.26%
14.87%
13.77%
14.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 5.45% vs 3.22% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is -0.25% vs -1.82% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 2.19% vs -0.70% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Medikit Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
23,781.46
41,899.00
-18,117.54
-43.24%
Other Operating Income
0.00
0.00
0.00
Total Operating income
23,781.46
41,899.00
-18,117.54
-43.24%
Raw Material Cost
15,343.73
25,723.00
-10,379.27
-40.35%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.67
29.00
-21.33
-73.55%
Selling and Distribution Expenses
3,867.26
9,579.00
-5,711.74
-59.63%
Other Expenses
29.17
364.70
-335.53
-92.00%
Total Expenditure (Excl Depreciation)
19,510.33
38,978.00
-19,467.67
-49.95%
Operating Profit (PBDIT) excl Other Income
4,271.13
2,921.00
1,350.13
46.22%
Other Income
248.74
1,941.00
-1,692.26
-87.18%
Operating Profit (PBDIT)
6,559.15
7,398.00
-838.85
-11.34%
Interest
7.67
29.00
-21.33
-73.55%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
8,437.73
16,176.00
-7,738.27
-47.84%
Depreciation
2,039.29
2,536.00
-496.71
-19.59%
Profit Before Tax
4,512.20
4,834.00
-321.80
-6.66%
Tax
1,506.11
1,125.00
381.11
33.88%
Provisions and contingencies
0
0
0.00
Profit After Tax
3,006.08
3,708.00
-701.92
-18.93%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
3,006.08
3,708.00
-701.92
-18.93%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,006.08
3,708.00
-701.92
-18.93%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
46,781.03
44,034.00
2,747.03
6.24%
Earnings per share (EPS)
206.38
112.06
94.32
84.17%
Diluted Earnings per share
206.38
112.06
94.32
84.17%
Operating Profit Margin (Excl OI)
17.96%
6.97%
0.00
10.99%
Gross Profit Margin
27.55%
17.59%
0.00
9.96%
PAT Margin
12.64%
8.85%
0.00
3.79%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 2,378.15 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 5.45% vs 3.22% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 300.61 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is -0.25% vs -1.82% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 631.04 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 2.19% vs -0.70% in Mar 2025

Annual - Interest
Interest 0.77 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.96%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025